J Bacteriol Virol.  2003 Mar;33(1):11-18.

Analysis of Clarithromycin Resistance of Helicobacter pylori Isolated in Korea

Affiliations
  • 1Department of Microbiology, Kosin Medical College, 34 Amnamdong, Seogu, Busan 602-702, Korea. microdal@ns.kosinmed.or.kr

Abstract

Forty-four strains of Helicobacter pylori were isolated from Kosin Medical Center were tested of resistance to antimicrobial agents, and the mechanism of resistance to clarithromycin was investigated. We determined the MICs of amoxicillin, amoxicillin/clavulanic acid, clarithromycin, and metronidazole by agar and broth dilution method. To detect the mutations of 23S rRNA which is associated with clarithromycin resistance, a 3'-mismatched polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) analysis with restriction enzymes BbsI and BsaI were performed. The nucleotide sequence of 23S rRNA was determined. All H. pylori strains appeared to be susceptible to amoxicillin/clavulinic acid, but 2.3% of strains (1 strain) are resistant to amoxicillin, 13.6% (6 strains) to clarithromycin, and 15.9% (7 strains) to metronidazole. No PCR products was observed by the 3'-mismatched PCR. A 291 bp of PCR product was not digested by BbsI, but was digested by BsaI, which was a characteristic of the A2143G point mutation in the 23S rRNA gene. The nucleotide sequencing analysis revealed that all resistant strains had A2143G, T2182C, and T2244C mutations in 23S rRNA gene.

Keyword

Helicobacter pylori; 23S rRNA; Mutation; Clarithromycin resistance; PCR; RFLP

MeSH Terms

Agar
Amoxicillin
Anti-Infective Agents
Base Sequence
Clarithromycin*
Genes, rRNA
Helicobacter pylori*
Helicobacter*
Korea*
Metronidazole
Point Mutation
Polymerase Chain Reaction
Polymorphism, Restriction Fragment Length
Agar
Amoxicillin
Anti-Infective Agents
Clarithromycin
Metronidazole
Full Text Links
  • JBV
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr